Safeguard Scientifics (Safeguard Scientifics) Risk Assessment

View and export this data going back to 1971. Start your Free Trial

What is Safeguard Scientifics Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Safeguard Scientifics is: No Data: Cannot be evaluated.

Competitive Comparison of Safeguard Scientifics's Risk Assessment

For the Asset Management subindustry, Safeguard Scientifics's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Safeguard Scientifics's Risk Assessment Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Safeguard Scientifics's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Safeguard Scientifics's Risk Assessment falls into.

Safeguard Scientifics (OTCPK:SFES) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Safeguard Scientifics Risk Assessment Related Terms

Thank you for viewing the detailed overview of Safeguard Scientifics's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Safeguard Scientifics (Safeguard Scientifics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Safeguard Scientifics Inc (OTCPK:SFES) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

SFU:Germany

Address

150 N. Radnor Chester Road, Suite F-200, Radnor, PA, USA, 19087

Website

https://www.safeguard.com

Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media, and other companies. Safeguard generally promotes the growth and development of these companies through Board representation and minority equity ownership. In addition to supporting the companies, Safeguard's strategy focuses on pursuing monetization opportunities in order to return value to shareholders.

Executives

Satterfield Thomas A Jr	10 percent owner	2609 CALDWELL MILL LN, BIRMINGHAM AL 35243
Beth Michelson	director	C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Ross D Demont	director	51 PICKWICK ROAD, NEWTON MA 02465
Manko Joseph M. Jr.	director	1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Bob Rosenthal	director	20 NEWBURY ST, BOSTON MA 02116
Mark Herndon	officer: SVP & Chief Financial Officer	C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Eric Salzman	officer: Chief Restructuring Officer	C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008
Ira M Lubert	director	C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102
John Joseph Roberts	director	1007 CANTERBURY LANE, VILLANOVA PA 19085
Brian J Sisko	officer: Senior V.P. & General Counsel	435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087
Russell D Glass	director	170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
David A Kille	officer: Senior VP & CFO	C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Maureen F Morrison	director	C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097
Stephen T Zarrilli	officer: Acting Sr VP & Acting CFO	FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Andrew E Lietz	director	P O BOX 738, RYE NH 03870